Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy

Zhu D., Judge PK., Francis ST., Che Z., Rayner JJ., Buchanan C., Mayne KJ., Stevens W., Bley T., Bhandary N., Byrne C., Cejka V., Chapman D., Cox EF., Dasgupta T., Malijan GB., Nicholas R., Phelan P., Smith E., Tunnicliffe EM., Wooding N., Nangaku M., Cherney DZI., Selby NM., Taal M., Steubl D., Aoqui C., Wanner C., Emberson JR., Landray MJ., Baigent C., Staplin N., Herrington WG., Haynes R.